These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38074683)

  • 1. Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.
    Khalifa J; Thébault N; Scarlata CM; Norkowski E; Massabeau C; Brouchet L; Peries Bataille S; Casaroli C; Vaz L; Valle C; Sarot E; Saint-Laurent N; Martin E; Pages PB; Millière A; Mazières J; Cohen-Jonathan Moyal E; Lauzéral-Vizcaïno F; Ayyoub M
    Front Oncol; 2023; 13():1269166. PubMed ID: 38074683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.
    Yang H; Sun B; Ma W; Fan L; Xu K; Jia Y; Xu J; Wang Z; Yao F
    EBioMedicine; 2022 Oct; 84():104265. PubMed ID: 36116212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
    Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
    Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer.
    He M; He Q; Cai X; Liu J; Deng H; Li F; Zhong R; Lu Y; Peng H; Wu X; Chen Z; Lao S; Li C; Li J; He J; Liang W
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
    Dickhoff C; Senan S; Schneiders FL; Veltman J; Hashemi S; Daniels JMA; Fransen M; Heineman DJ; Radonic T; van de Ven PM; Bartelink IH; Meijboom LJ; Garcia-Vallejo JJ; Oprea-Lager DE; de Gruijl TD; Bahce I
    BMC Cancer; 2020 Aug; 20(1):764. PubMed ID: 32795284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles.
    Koukourakis MI; Giatromanolaki A
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188704. PubMed ID: 35227831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach.
    Knopf P; Stowbur D; Hoffmann SHL; Fransen MF; Schwenck J; Pichler BJ; Kneilling M
    Mol Imaging Biol; 2023 Jun; 25(3):606-618. PubMed ID: 36600172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy.
    Habenicht LM; Albershardt TC; Iritani BM; Ruddell A
    Oncoimmunology; 2016 Aug; 5(8):e1204505. PubMed ID: 27622075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced suppression of antitumor reactivity and depression of TCRzeta expression in tumor-draining lymph node lymphocytes: possible relationship to the Th2 pathway.
    Fu EJ; Arca MJ; Hain JM; Krinock R; Rado J; Cameron MJ; Chang AE; Sondak VK
    J Immunother; 1997 Mar; 20(2):111-22. PubMed ID: 9087383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment.
    van Luijk IF; Smith SM; Marte Ojeda MC; Oei AL; Kenter GG; Jordanova ES
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: A pilot study.
    Murthy V; Katzman DP; Tsay JJ; Bessich JL; Michaud GC; Rafeq S; Minehart J; Mangalick K; de Lafaille MAC; Goparaju C; Pass H; Sterman DH
    Lung Cancer; 2019 Nov; 137():94-99. PubMed ID: 31563736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.
    Hiramatsu S; Tanaka H; Nishimura J; Sakimura C; Tamura T; Toyokawa T; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Immunol; 2018 Apr; 19(1):13. PubMed ID: 29661142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma.
    Chotard G; Capdepont M; Denost Q; Smith D; Vendrely V; Rullier E; Rullier A
    Virchows Arch; 2021 Oct; 479(4):657-666. PubMed ID: 33983519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound.
    Bugalho A; Martins C; Silva Z; Nunes G; Mendes AS; Ferreira I; Videira PA
    Tumour Biol; 2016 Jan; 37(1):953-61. PubMed ID: 26264617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.
    Casarrubios M; Provencio M; Nadal E; Insa A; Del Rosario García-Campelo M; Lázaro-Quintela M; Dómine M; Majem M; Rodriguez-Abreu D; Martinez-Marti A; De Castro Carpeño J; Cobo M; López Vivanco G; Del Barco E; Bernabé R; Viñolas N; Barneto Aranda I; Massuti B; Sierra-Rodero B; Martinez-Toledo C; Fernández-Miranda I; Serna-Blanco R; Romero A; Calvo V; Cruz-Bermúdez A
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes.
    Li YL; Chen CH; Chen JY; Lai YS; Wang SC; Jiang SS; Hung WC
    Oncoimmunology; 2020 Oct; 9(1):1830513. PubMed ID: 33117603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation.
    Giatromanolaki A; Koukourakis IM; Chatzipantelis P; Kouroupi M; Balaska K; Koukourakis MI
    Immunol Res; 2020 Dec; 68(6):363-372. PubMed ID: 33150567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the relationship between tumor regression grade and lymph node regression grade].
    Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.